First person profile: Dr Carl June: Dr June recently participated on a panel with the FDA to discuss the next steps needed to expand CAR T-cell therapy into areas other than blood cancers.

Subjects

Subjects :

Humans
United States
History, 21st Century
Neoplasms therapy
Immunotherapy, Adoptive methods
United States Food and Drug Administration
Receptors, Chimeric Antigen immunology

Details

Language :

English

ISSN :

1097-0142

Volume :

130

Issue :

14

Database :

MEDLINE

Journal :

Cancer

Publication Type :

Periodical

Accession number :

38943467

Full Text :

https://doi.org/10.1002/cncr.35420